Palvella Therapeutics Financial Overview
Palvella Therapeutics's market cap is currently $1.09B. The company's EPS TTM is $-1.03; its P/E ratio is -7.63; Palvella Therapeutics is scheduled to report earnings on November 11, 2025, and the estimated EPS forecast is $-0.91. See an overview of income statement, balance sheet, and cash flow financials.
